Company strengthened with seasoned governance
and capacity
/THIS NEWS RELEASE, PROVIDED PURSUANT TO
APPLICABLE CANADIAN REQUIREMENTS, IS NOT FOR DISTRIBUTION TO U.S.
NEWS SERVICES OR FOR DISSEMINATION IN THE
UNITED STATES, AND DOES NOT CONSTITUTE AN OFFER OF THE
SECURITIES DESCRIBED HEREIN. THESE SECURITIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES
SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS,
AND MAY NOT BE OFFERED OR SOLD IN THE
UNITED STATES OR TO U.S. PERSONS ABSENT REGISTRATION OR
APPLICABLE EXEMPTION FROM REGISTRATION REQUIREMENTS./
VANCOUVER, June 24, 2019 /CNW/ - Geyser Brands Inc
(TSXV:GYSR) ("Geyser Brands" or the "Company") is pleased to
announce that the Company has appointed Dr. Bin Huang to the Board
of Directors, subject to approval from the TSXV Exchange.
Dr. Huang is a seasoned life-sciences executive with experience
in strategy and new business development, financing and public
markets, corporate governance, as well as operations management in
North America and Asia. Her work experience includes 18 years as
CEO of life-sciences companies, most recently CEO of Emerald
Health Therapeutics Inc., senior management roles in both startups
and Fortune 500 corporations, analyst and partner at a premier
investment banking firm, board member of public and private
companies as well as NGOs, strategic adviser to organizations and
entrepreneurs. She has a proven track record in dealing with
multiple stakeholders, leading cross-functional and multinational
teams, communicating with boards of directors and shareholders,
managing strategic partnerships including CROs and CMOs. Dr. Huang
holds a PhD in cell biology (University of East Anglia, UK), Postdoctoral in plant
molecular biology (Purdue University,
USA), MBA in finance (University of Toronto, Canada).
"The Board of Directors are extremely pleased that Dr. Huang has
accepted our offer to join our growing company" said Brad Kersch, Chairman of the Board. "Her depth
of experience in life sciences and her leadership demonstrated in
the corporate world, particularly in the Cannabis industry, will
provide unparalleled value and oversight to the Company's
development."
The Board of Directors also announces the resignation of
David Eto from the Board, in order
to take up a more operational role in the Company. More details
will follow in due course.
The Company is also pleased to announce the appointment of
Gordon Clissold as Chief Financial
Officer of the Company effective immediately, subject to approval
from the TSXV Exchange. CEO Andreas
Thatcher said, "Gordon brings tremendous experience and
added bench strength in both operational and financial management
and we are very pleased he's agreed to join the Geyser executive
team."
Gordon is a Chartered Professional Accountant with over 20 years
of experience as an operational and financial manager for both
public and private companies. His career experience spans
multiple industries that include technology, manufacturing,
wholesale distribution, and professional services. His management
competencies encompass organizational leadership, strategic
planning, corporate finance, financial modelling, ERP and financial
systems implementation, internal control development, and due
diligence for mergers and acquisitions.
Gordon obtained his accounting designation in 1995, was awarded
the Fellowship designation in 2006, and has been awarded life
membership as Chartered Professional Accountant. He is a Past
President of the Certified General Accountants of BC, in addition
to having served nine years as a director on their board of
governors and a three-year term on the national board of
CGA-Canada.
Mr. Clissold replaces Barry
McKnight as Chief Financial Officer. The Board of Directors
thanks Mr. McKnight for his service to the Company and wishes him
well in his future endeavors.
The Company also announces that as a result of Mr. McKnight's
departure, Jennifer Hanson will
replace as the Company's Corporate Secretary, subject to
approval from the TSXV Exchange. Ms. Hanson brings over 6
years' experience acting as Corporate Secretary for several
publicly listed companies. CEO Andreas
Thatcher said, "We couldn't be happier to have Jennifer come
on board in this role. She brings a tremendous amount of knowledge
and expertise."
ABOUT GEYSER BRANDS
Geyser Brands Inc builds
health-based hemp CBD consumer products in the nutraceutical,
cosmetics, food & beverage and pet sectors world-wide. R &
D investment in NanoFusion, a proprietary all-natural
nanotechnology, delivers topical, cream, beverages and baked goods,
oil, and tincture formulations with superior bio-availability and
water-solubility.
Geyser Brands owns a Health-Canada approved Licensed Producer
(LP) in Port Coquitlam, B.C. that
holds cultivation and processing licenses and is anticipating its R
& D and sales licenses. The company is exclusively focusing on
leveraging these assets to provide the regulatory infrastructure
for its global brands and distribution strategy, acquiring hemp-
and plant-based brands and infusing them with new CBD product lines
in jurisdictions where the therapeutic ingredient is legal. The
company's proprietary NanoFusion technology surrounds oils and
solves for the insolubility of CBD. Geyser Brands will utilize both
of its GMP- licensed facilities in British Columbia for the manufacturing and
distribution of its hemp and CBD-based products
internationally.
On Behalf of the Board of Directors
Andreas Thatcher
Director and CEO
CAUTIONARY AND FORWARD-LOOKING STATEMENTS
This news release contains forward‐looking statements and
forward‐looking information within the meaning of applicable
securities laws. These statements relate to future events or future
performance. All statements other than statements of historical
fact may be forward‐looking statements or information.
Forward‐looking statements and information are often, but not
always, identified by the use of words such as "appear", "seek",
"anticipate", "plan", "continue", "estimate", "approximate",
"expect", "may", "will", "project", "predict", "potential",
"targeting", "intend", "could", "might", "should", "believe",
"would" and similar expressions.
Forward-looking statements and information are provided for the
purpose of providing information about the current expectations and
plans of management of the Company relating to the future. Readers
are cautioned that reliance on such statements and information may
not be appropriate for other purposes, such as making investment
decisions. Since forward‐looking statements and information address
future events and conditions, by their very nature they involve
inherent risks and uncertainties. Actual results could differ
materially from those currently anticipated due to a number of
factors and risks. These include, but are not limited to, the risks
associated with the marijuana industry in general such as
operational risks in growing; competition; incorrect assessment of
the value and potential benefits of various transactions; ability
to access sufficient capital from internal and external sources;
failure to obtain required regulatory and other approvals and
changes in legislation, including but not limited to tax laws and
government regulations.
NEITHER TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES
PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX
VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR
ACCURACY OF THIS RELEASE.
SOURCE Geyser Brands Inc.